Skip to main content
Top
Published in: Infection 1/2022

01-02-2022 | Pneumococcus | Original Paper

Lobar (croupous) pneumonia: old and new data

Authors: Vsevolod A. Zinserling, Vladimir V. Swistunov, Alexander D. Botvinkin, Lilia A. Stepanenko, Angelica E. Makarova

Published in: Infection | Issue 1/2022

Login to get access

Abstract

Background and aim

Pneumonia remains one of the most frequent death causes worldwide. Among the etiological factors S. pneumoniae-causing lobar pneumonia plays a leading role. According to current textbook knowledge at least three sequential stages of lobar pneumonia are distinguished: congestion, red hepatization and gray hepatization. However, there are no detailed data supporting this stage concept. There are also controversial views on its etiology. In this study, the lung changes in lobar pneumonia were related to the cause and duration of the disease. In addition, the complications of the disease were evaluated. PCR studies verified the etiology of pneumonia.

Material and methods

Lobar pneumonia was analyzed in 252 post mortem cases examined in a large hospital in Irkutsk. The pathology, etiology of pneumonia, course of disease and cause of death were recorded and correlated to its clinical course and duration. In the second part of the study, the results in 95 patients were analyzed in detail and related to PCR findings.

Results

Most patients were adult men of low social status who showed signs of severe alcoholism. Lobar pneumonia was observed in 85% of the patients, while the remaining patients showed sublobar (“lobular”, focal) lung involvement. Histologically, three patterns of inflammation were observed, which in most patients occurred concurrently in different parts of the involved lobe: “congestion”, characterized by serous exudation with multiple cocci (41% of cases), “red hepatization” (41% of cases) and “gray hepatization” (100% of cases). The latter pattern was subdivided into three subgroups according to the ratio of fibrin—neutrophils and the presence of macrophages. The mean number of different histological patterns observed per patient was 3.8. There was no correlation between the inflammatory patterns and the duration of the disease. In 23% of the patients, the cause of death was of pulmonary origin, while the remaining patients died of extrapulmonary complications (i.e. acute heart failure 26%, acute vascular insufficiency 15% purulent meningitis 11–24.3%. In 29/95 patients (20 with lobar and 9 with focal pneumonia) pneumococcal etiology of pneumonia was established by PCR.

Conclusion

Lobar pneumonia is a distinct clinico-pathological entity caused by S. pneumoniae, demonstrated by PCR testing and/or cytological examinations. Bacteriologic studies frequently give falsenegative results. Lobar pneumonia is characterized by three main histopathological patterns (congestion or microbeous edema, and red and gray hepatization) which usually occur side by side and not in chronological order. Early death is often related to heart failure and septic shock, while meningitis is a frequent complication later in the course.
Literature
1.
go back to reference Engleberg NC, Di Rita V, Dermodi TS. Schaechter’s mechanisms of microbial disease. Philadelphia: Lippincott Williams & Wilkins; 2007. Engleberg NC, Di Rita V, Dermodi TS. Schaechter’s mechanisms of microbial disease. Philadelphia: Lippincott Williams & Wilkins; 2007.
2.
go back to reference Kumar V, Abbas A, Fausto N. Robbins and Cotran pathologic basis of the disease. 9th ed. Philadelphia: Elsevier Saunders; 2020. Kumar V, Abbas A, Fausto N. Robbins and Cotran pathologic basis of the disease. 9th ed. Philadelphia: Elsevier Saunders; 2020.
3.
go back to reference Rokitansky C. Handbuch der speziellen pathologischen Anatomie, II. Wien; 1842. Rokitansky C. Handbuch der speziellen pathologischen Anatomie, II. Wien; 1842.
4.
go back to reference Zinserling A. Pathologische Anatomie der wichtigsten Formen bakteriellen Pneumonien. Zbl Allg Path path Anat. 1990;136:3–13. Zinserling A. Pathologische Anatomie der wichtigsten Formen bakteriellen Pneumonien. Zbl Allg Path path Anat. 1990;136:3–13.
5.
go back to reference Zinserling VD. Several questions of pathogenesis of croupous pneumonia in the light of new morphological investigations. Clin Med (Russ). 1939;9–10:3–12. Zinserling VD. Several questions of pathogenesis of croupous pneumonia in the light of new morphological investigations. Clin Med (Russ). 1939;9–10:3–12.
6.
go back to reference Zinserling VD, Zinserling AV (1963) Pathologic anatomy of acute pneumonias of different etiology (Rus), Leningrad, «Medgiz» Zinserling VD, Zinserling AV (1963) Pathologic anatomy of acute pneumonias of different etiology (Rus), Leningrad, «Medgiz»
7.
go back to reference Farnworth SL, Henderson NC, MacKinnon AC, et al. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am J Pathol. 2008;172:395–405.CrossRef Farnworth SL, Henderson NC, MacKinnon AC, et al. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am J Pathol. 2008;172:395–405.CrossRef
8.
go back to reference Fujiki R, Kawayama T, Ulyama T, et al. The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother. 2007;13:157–65.CrossRef Fujiki R, Kawayama T, Ulyama T, et al. The risk factors for mortality of community-acquired pneumonia in Japan. J Infect Chemother. 2007;13:157–65.CrossRef
9.
go back to reference Garcia-Vidal C, Fernàndez-Sabe N, Carratalà J, et al. Early mortality in patients with community acquired pneumonia: causes and risk factors. Eur Respir J. 2008;32:733–9.CrossRef Garcia-Vidal C, Fernàndez-Sabe N, Carratalà J, et al. Early mortality in patients with community acquired pneumonia: causes and risk factors. Eur Respir J. 2008;32:733–9.CrossRef
10.
go back to reference Glover DT, Hollingshead SK, Briles DE. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect Immun. 2008;76:2767–76.CrossRef Glover DT, Hollingshead SK, Briles DE. Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis. Infect Immun. 2008;76:2767–76.CrossRef
11.
go back to reference Kafka D, Ling E, Feldman G, et al. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int Immunol. 2008;20:1139–46.CrossRef Kafka D, Ling E, Feldman G, et al. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int Immunol. 2008;20:1139–46.CrossRef
12.
go back to reference Maus UA, Srivastava M, Paton JC, et al. Pneumolysin-induced lung injury is independent of leucocyte trafficking into the alveolar space. J Immunol. 2004;173:1307–12.CrossRef Maus UA, Srivastava M, Paton JC, et al. Pneumolysin-induced lung injury is independent of leucocyte trafficking into the alveolar space. J Immunol. 2004;173:1307–12.CrossRef
13.
go back to reference Travis WD, Colbi TV, Koss MN, et al. Non-neoplastic disorders of the lower respiratory tract. Atlas of nontumor pathology. First series. Washington: Fascicle 2 AFIP; 2002. Travis WD, Colbi TV, Koss MN, et al. Non-neoplastic disorders of the lower respiratory tract. Atlas of nontumor pathology. First series. Washington: Fascicle 2 AFIP; 2002.
14.
go back to reference Yuan FF, Marks K, Wong M, et al. Clinical relevance of TLR2, TLR3, CD14 and Fc gamma RIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol. 2008;86:268–70.CrossRef Yuan FF, Marks K, Wong M, et al. Clinical relevance of TLR2, TLR3, CD14 and Fc gamma RIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol. 2008;86:268–70.CrossRef
Metadata
Title
Lobar (croupous) pneumonia: old and new data
Authors
Vsevolod A. Zinserling
Vladimir V. Swistunov
Alexander D. Botvinkin
Lilia A. Stepanenko
Angelica E. Makarova
Publication date
01-02-2022
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 1/2022
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-021-01689-4

Other articles of this Issue 1/2022

Infection 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine